Short-term versus indefinite anticoagulant therapy for secondary prevention of unprovoked venous thromboembolism: a decision analysis

Back

ESC Premium Access

Short-term versus indefinite anticoagulant therapy for secondary prevention of unprovoked venous thromboembolism: a decision analysis

Session: Venous thrombosis and anticoagulation

Topic: Venous Disease

Speaker: Mr F. Khan (Ottawa, CA)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Faizan Khan

The Ottawa Hospital, Ottawa (Canada)

0 follower

6 more presentations in this session

Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial

Speaker: Doctor A. Kalayci Karabay (Boston, US)

Access

Abstract

Slides

Sex differences in the clinical characteristics and outcomes of patients with venous thromboembolism: from the COMMAND VTE Registry

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)

Access

Abstract

Slides

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism: D-Dimer inter-assay concordance

Speaker: Mr F. Khan (Ottawa, CA)

Access

Abstract

Slides

Prognostic impact of non-compliance with guidelines-recommended treatment of acute pulmonary embolism: Results of a prospective multicenter registry

Speaker: Professor N. Meneveau (Besancon, FR)

Access

Abstract

Slides

Evaluation of VTE-BLEED for predicting intracranial or fatal bleedings in stable anticoagulated patients with venous thromboembolism

Speaker: Doctor E. Klok (Leiden, NL)

Access

Abstract

Access the full session

Venous thrombosis and anticoagulation

Speakers: Mr F. Khan, Doctor A. Kalayci Karabay, Doctor Y. Yoshikawa, Mr F. Khan, Professor N. Meneveau...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources